Volume 18, Issue 3, Pages (March 2011)

Slides:



Advertisements
Similar presentations
Volume 16, Issue 1, Pages (January 2009)
Advertisements

Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Volume 12, Issue 5, Pages (May 2004)
Plk1 Controls the Nek2A-PP1γ Antagonism in Centrosome Disjunction
Ambiguous Origin: Two Sides of an Ephrin Receptor Tyrosine Kinase
Generation of a dual-labeled fluorescence biosensor for Crk-II phosphorylation using solid-phase expressed protein ligation  Graham J Cotton, Tom W Muir 
Volume 32, Issue 1, Pages (October 2008)
Volume 13, Issue 4, Pages (April 2006)
Volume 49, Issue 6, Pages (March 2013)
Volume 25, Issue 8, Pages e4 (August 2017)
Volume 23, Issue 4, Pages (April 2015)
Volume 22, Issue 3, Pages (May 2006)
Glen S. Cho, Jack W. Szostak  Chemistry & Biology 
Volume 125, Issue 1, Pages (April 2006)
Volume 11, Issue 6, Pages (June 2004)
The Structure of the Cytoplasmic Domain of the Chloride Channel ClC-Ka Reveals a Conserved Interaction Interface  Sandra Markovic, Raimund Dutzler  Structure 
The Molecular Basis of Aichi Virus 3A Protein Activation of Phosphatidylinositol 4 Kinase IIIβ, PI4KB, through ACBD3  Jacob A. McPhail, Erik H. Ottosen,
X-Ray Crystal Structure and Functional Analysis of Vaccinia Virus K3L Reveals Molecular Determinants for PKR Subversion and Substrate Recognition  Arvin.
Volume 17, Issue 11, Pages (November 2010)
Volume 7, Issue 2, Pages (February 2001)
The TGFβ Receptor Activation Process
Ivar Ilves, Tatjana Petojevic, James J. Pesavento, Michael R. Botchan 
Volume 15, Issue 11, Pages (November 2008)
Selective Degradation of Ubiquitinated Sic1 by Purified 26S Proteasome Yields Active S Phase Cyclin-Cdk  Rati Verma, Hayes McDonald, John R Yates, Raymond.
Volume 48, Issue 2, Pages (October 2005)
Volume 15, Issue 4, Pages (April 2008)
Phospho-Pon Binding-Mediated Fine-Tuning of Plk1 Activity
Volume 21, Issue 8, Pages (August 2014)
Plk1 Controls the Nek2A-PP1γ Antagonism in Centrosome Disjunction
Volume 23, Issue 8, Pages (August 2016)
Calnexin Controls the STAT3-Mediated Transcriptional Response to EGF
Volume 17, Issue 1, Pages (January 2010)
Volume 18, Issue 3, Pages (February 2008)
A Subdomain Swap Strategy for Reengineering Nonribosomal Peptides
Volume 17, Issue 1, Pages (January 2005)
Volume 18, Issue 12, Pages (December 2010)
Volume 37, Issue 2, Pages (January 2010)
A Dual E3 Mechanism for Rub1 Ligation to Cdc53
Semisynthetic Src SH2 Domains Demonstrate Altered Phosphopeptide Specificity Induced by Incorporation of Unnatural Lysine Derivatives  Satpal Virdee,
Volume 20, Issue 1, Pages (January 2013)
Volume 17, Issue 5, Pages (March 2007)
Volume 24, Issue 12, Pages e5 (December 2017)
Volume 22, Issue 2, Pages (February 2015)
Structural Basis for Specific Recognition of Reelin by Its Receptors
An Electrophoretic Mobility Shift Assay Identifies a Mechanistically Unique Inhibitor of Protein Sumoylation  Yeong Sang Kim, Katelyn Nagy, Samantha Keyser,
Volume 11, Issue 24, Pages (December 2001)
Andrei Kuzmichev, Thomas Jenuwein, Paul Tempst, Danny Reinberg 
Structural Insights into the pH-Dependent Conformational Change and Collagen Recognition of the Human Mannose Receptor  Zhenzheng Hu, Xiangyi Shi, Bowen.
A General Framework for Inhibitor Resistance in Protein Kinases
Hayun Lee, Yi Zhou, David W. Taylor, Dipali G. Sashital  Molecular Cell 
Structural Analysis of the Protein Phosphatase 1 Docking Motif: Molecular Description of Binding Specificities Identifies Interacting Proteins  Heike.
Scarlet S. Shell, Christopher D. Putnam, Richard D. Kolodner 
TopBP1 Activates the ATR-ATRIP Complex
Volume 13, Issue 4, Pages (April 2006)
Volume 12, Issue 2, Pages (August 2003)
Conformation-Selective ATP-Competitive Inhibitors Control Regulatory Interactions and Noncatalytic Functions of Mitogen-Activated Protein Kinases  Sanjay B.
Volume 24, Issue 9, Pages (September 2016)
Volume 129, Issue 2, Pages (April 2007)
Volume 15, Issue 7, Pages (July 2008)
Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Volume 61, Issue 2, Pages (January 2016)
Volume 24, Issue 6, Pages (June 2016)
Volume 23, Issue 2, Pages (July 2006)
Volume 15, Issue 9, Pages (September 2008)
Jue Wang, Jia-Wei Wu, Zhi-Xin Wang  Structure 
Volume 68, Issue 3, Pages e5 (November 2017)
Reconstitution of the Transcription Factor TFIIH
Volume 42, Issue 5, Pages (June 2011)
Volume 7, Issue 6, Pages (June 2001)
Fine Details of IGF-1R Activation, Inhibition, and Asymmetry Determined by Associated Hydrogen /Deuterium-Exchange and Peptide Mass Mapping  Damian Houde,
Presentation transcript:

Volume 18, Issue 3, Pages 361-371 (March 2011) A Semisynthetic Eph Receptor Tyrosine Kinase Provides Insight into Ligand- Induced Kinase Activation  Nikhil Singla, Hediye Erdjument-Bromage, Juha P. Himanen, Tom W. Muir, Dimitar B. Nikolov  Chemistry & Biology  Volume 18, Issue 3, Pages 361-371 (March 2011) DOI: 10.1016/j.chembiol.2011.01.011 Copyright © 2011 Elsevier Ltd Terms and Conditions

Chemistry & Biology 2011 18, 361-371DOI: (10. 1016/j. chembiol. 2011 Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 1 Summary of the EPL Strategy Intein-mediated thiolysis generates the Eph ECD α-thioester (I) (LBD: ligand binding domain, CR: cysteine rich region, FN III: fibronectin type III repeat). The intein-Fc-purification-tag fragment is separated by affinity chromatography. Protease treatment cleaves the SUMO fusion protein with histidine (His) purification tag and unmasks the cysteine residue at the N terminus of the Eph ICD (II) (JM: juxtamembrane region, Kinase: tyrosine kinase domain; His: purification tag). The two reactive building blocks I and II are chemically ligated to generate the semisynthetic Eph RTK sans the transmembrane helix (III). See also Figures S1 and S2. Chemistry & Biology 2011 18, 361-371DOI: (10.1016/j.chembiol.2011.01.011) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 2 Semisynthesis of Eph RTK (A) SEC (size exclusion chromatography) characterization of the products of the chemical ligation reaction. The major peaks I, II, and III correspond to the EphA4 ECD α-thioester (EphA4ECDthio), EphA4 ICD (cys-EphA4ICD-His), and the semisynthetic EphA4 receptor (EphA4ECD-EphA4ICD-His), respectively. An aliquot of the sample loaded on the SEC column (load) and the fractions under the corresponding peaks are resolved by SDS-PAGE. All shown SDS-PAGEs are Coomassie stained. (Mw) Molecular weight marker (in kilodaltons). (B) SDS-PAGE analysis of the semisynthetic EphA4 receptor purification. Fractions corresponding to peaks I and III were loaded on an immobilized metal ion affinity column (load). The unligated EphA4ECDthio impurity (lacking a histidine tag) is collected in the flow through (load FT) and the wash step (wash FT). Only the semisynthetic EphA4ECD-EphA4ICD-His protein binds to the column, which is then eluted (elute). (C) SEC profile for the eluted protein from the affinity column. The fractions under the major peak are resolved on SDS-PAGE and correspond to >95% pure semisynthetic EphA4 receptor. See also Figure S3. Chemistry & Biology 2011 18, 361-371DOI: (10.1016/j.chembiol.2011.01.011) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 3 Both the ECD and the ICD Retain Full Biological Activity in the Semisynthetic Eph Receptor (A) The semisynthetic Eph receptor (EphA4ECD-EphA4ICD-His) forms a specific complex with the Fc-tagged ephrin-A5 ligand (ephrin-A5-Fc), which can be pulled-down by Protein-A Sepharose beads (lane 1). The semisynthetic protein by itself does not bind to the beads (lane 2) whereas the binding of ephrin-A5-Fc alone to the beads is shown (lane 3). The SDS-PAGE is Coomassie stained. (Mw) Molecular weight marker (in kilodaltons). (B) Representative plots for the phosphorylation of peptide substrate at different concentration of the unligated (His-SUMO-EphA3ICD-His) (top panel) and ligated (EphA4ECD-EphA3ICD-His) (lower panel) EphA3 ICD using an ELISA-based assay. (C) Affinity for ATP of the EphA3 tyrosine kinase. Phosphorylation of a biotinylated peptide substrate by the unligated (His-SUMO-EphA3ICD-His) (top panel) and ligated (EphA4ECD-EphA3ICD-His) (lower panel) EphA3 ICD was monitored at different concentrations of ATP using an ELISA-based assay. The Km values for ATP were 110.6 ± 46.9 and 122.8 ± 42.9 μM for the unligated and ligated EphA3 ICD, respectively, comparable to previously reported values (Davis et al., 2008). (D) Western blot analysis for the semisynthetic Eph protein with EphA4 (EphA4ECD-EphA4ICD-His) (top panel) and EphA3 (EphA4ECD-EphA3ICD-His) (lower panel) ICD using phosphotyrosine antibody. The semisynthetic proteins are autophosphorylated (lane 1); Treatment with YOP phosphatase dephosphorylates them (lane 2) and the proteins are not autophosphorylated back upon addition of either Mg2+/ATP (lane 3) or phosphatase inhibitors (lane 4) individually. Simultaneous incubation of the dephosphorylated proteins with phosphatase inhibitors and Mg2+/ATP results in autophosphorylation of the semisynthetic Eph proteins (lane 5). (E) Progress curves for the transphosphorylation of peptide substrate by semisynthetic Eph protein (EphA4ECD-EphA3ICD-His), before (blue) and after (orange) phosphatase treatment using the ELISA-based assay. Error bars represent the SD of three independent reactions. See also Figure S4. Chemistry & Biology 2011 18, 361-371DOI: (10.1016/j.chembiol.2011.01.011) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 4 Kinase Domain Activation in the Semisynthetic Eph Receptor after Stimulation with Ephrin Ligand (A) Autoradiograph for monitoring the semisynthetic EphA4 receptor (EphA4ECD-EphA4ICD-His) autophosphorylation over a period of time alone or in complex with dimeric (ephrin-A5-Fc) and preclustered (ephrin-A5-Fc + anti-Fc antibody, Fc-Ab) ephrin ligand. Progress curves were plotted for EphA4 by itself (green), in complex with dimeric (red) and preclustered (blue) ephrin ligand as quantified using a PhosphorImager. (B) Loss of ligand-induced autophosphorylation of the semisynthetic Eph receptor in presence of peptide inhibitor. Autoradiograph for monitoring the semisynthetic EphA4 receptor (EphA4ECD-EphA4ICD-His) autophosphorylation over a period of time alone or in complex with dimeric (ephrin-A5-Fc) ephrin ligand in the presence and absence of a peptide Eph antagonist. Progress curves were plotted for EphA4 by itself (green) and in complex with dimeric ephrin ligand with (cyan) and without (red) preincubation with the peptide inhibitor as quantified using a PhosphorImager. Error bars represent the SD of three independent reactions. See also Figure S5. Chemistry & Biology 2011 18, 361-371DOI: (10.1016/j.chembiol.2011.01.011) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 5 Analysis of the Phosphorylation Time Courses Of Individual Tyrosine Residues in the Semisynthetic Eph Receptor after Stimulation with Ephrin (A) Phosphoproteomics analysis. The phosphorylation levels of the semisynthetic receptor juxtamembrane loop tyrosine residues were quantified using MS/MS spectral counts. Progress curves for the autophosphorylation of the individual juxtamembrane tyrosine residues (YJM1 and YJM2) alone, as well as for their joint phosphorylation, YJM1+JM2, in the absence or presence of dimeric and preclustered ephrin ligand are colored as indicated. (B) Progress curves for the autophosphorylation of the activation loop tyrosine residue, Yact, in the semisynthetic receptor quantified using MS/MS spectral counts, in the absence (green) or presence of dimeric (red) and preclustered (blue) ephrin ligand. For each time point, the experimental data from three technical LC-MS/MS replicates performed on same amount of substrate was merged. (C) Ligand-induced autophosphorylation of semisynthetic Eph receptors, wild-type (WT) and those with juxtamembrane tyrosine mutations (YJM1F, YJM2F and YJM1+JM2F). Autoradiographs were quantified with PhosphorImager and are colored as indicated. Error bars represent the SD from three independent reactions. See also Figures S6 and S7. Chemistry & Biology 2011 18, 361-371DOI: (10.1016/j.chembiol.2011.01.011) Copyright © 2011 Elsevier Ltd Terms and Conditions